Correction: CLCA4 inhibits bladder cancer cell proliferation, migration, and invasion by suppressing the PI3K/AKT pathway

Teng Hou; Lijie Zhou; Longwang Wang; Gallina Kazobinka; Xiaoping Zhang; Zhaohui Chen

doi:10.18632/oncotarget.26656

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Learn about our FREE

Post-Publication Promotion Services

50% on all publication fees until the end of 2024.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Corrections:

Correction: CLCA4 inhibits bladder cancer cell proliferation, migration, and invasion by suppressing the PI3K/AKT pathway

PDF | How to cite

Oncotarget. 2019; 10:1010-1010. https://doi.org/10.18632/oncotarget.26656

Metrics: PDF 1700 views | ?

Teng Hou^1,*, Lijie Zhou^1,*, Longwang Wang^1,2, Gallina Kazobinka¹, Xiaoping Zhang¹ and Zhaohui Chen¹

¹ Department of Urology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
² Department of Urology, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi 330008, China
^* These authors have contributed equally to this work

Published: January 29, 2019

This article has been corrected: The correct affiliation information is given below:

¹ Department of Urology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China

Original article: Oncotarget. 2017; 8:93001-93013. DOI: https://doi.org/10.18632/oncotarget.21724.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 26656

Publication Alerts

Post-Publication Promotion

Publication Discount

Corrections:

Correction: CLCA4 inhibits bladder cancer cell proliferation, migration, and invasion by suppressing the PI3K/AKT pathway